Are we aiming for different metabolic targets in heart failure patients?

Brito, J.; Agostinho, João R.; Duarte, C.; Silva, B.; Couto Pereira, Sara Cristina; Morais, Pedro; Cunha, Nelson; Rodrigues, Tiago; Antonio, P. S.; Santos, R.; Nunes-Ferreira, Afonso; Rigueira, Joana; Aguiar-Ricardo, Inês; Pinto, Fausto J.; Brito, Dulce

http://hdl.handle.net/10451/45896

Utilize este identificador para referenciar este registo.

Contacte-nos

Autores

Brito, J.

Agostinho, João R.

Duarte, C.

Silva, B.

Couto Pereira, Sara Cristina

Morais, Pedro

Cunha, Nelson

Rodrigues, Tiago

Antonio, P. S.

Santos, R.

Resumo(s)

Introduction: Metabolic control plays an important role on major cardiovascular events (MACE) prevention. The 2019 ESC guidelines on dyslipidaemia management recommend tighter LDL-cholesterol (LDL-C) control in order to prevent cardiovascular events. However, it is not yet proven that thigh control of dyslipidaemia, glycaemic levels and body mass index (BMI) in Heart Failure (HF) patients (pts) have an impact on prognosis. Objective: To evaluate the impact of LDL-C, HbA1c and BMI values on HF pts mortality and MACE rates.

Descrição

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model).

Palavras-chave

Chronic heart failure Lifestyle modification

URI

http://hdl.handle.net/10451/45896

Citação

European Heart Journal, Volume 41, Issue Supplement_2, November 2020, ehaa946.1044

Editora

Oxford University Press

DOI

10.1093/ehjci/ehaa946.1044

Coleções

FM-CCUL-Artigos em Revistas Internacionais

Métricas Alternativas

Ver registo completo